NCT05385250View on ClinicalTrials.gov

Bone-sparing Chemoradiotherapy for Anal Cancer - DACG-II

NAActive, not recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

August 23, 2021

Primary Completion Date

January 1, 2025

Study Completion Date

March 1, 2026

Conditions
Anal CancerRadiotherapy Side Effect
Interventions
OTHER

Bone sparring radiotherapy

Observation of late side effects from the pelvic bones after bone-sparring radiotherapy for anal cancer

Trial Locations (1)

8200

Aarhus University Hospital, Aarhus

All Listed Sponsors
collaborator

Herlev Hospital

OTHER

collaborator

Zealand University Hospital

OTHER

collaborator

Vejle Hospital

OTHER

lead

Karen-Lise Garm Spindler

OTHER